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Purpose:Despiteminimal invasiveness and high success rate, guidelines still prescribe voiding Cystourethrogram
(VCUG) after endoscopic treatment for vesicoureteral reﬂux (VUR) in children.
The aim of this paperwas to analyzewhether intraoperative ultrasound (IO-US) could improve surgical accuracy
and perioperative counseling, thus potentially decreasing the need for postoperative VCUG.
Methods: We selected children treated for moderate to high grade VUR, renal scarring or repeated infections
under antibiotic prophylaxis from January to December 2015. Endoscopic injection was combined with IO-US
to detect optimal needle placement and to guide mound formation. IO-US ﬁndings were compared to surgeon
opinion and postoperative VCUG, performed 3 months after surgery. All patients were followed-up for 1 year.
Results: A signiﬁcant relationship was found between IO-US mound height (p = 0.003) or localization
(p b 0.0005) and VCUG. Success of endoscopic treatment vs persistence of reﬂux groups had a mean mound
height of 10.62 ± 1.36 mm and 8.39 ± 1.08 mm respectively (p b 0.0005).
Height maintained a signiﬁcant correlation with success in simple and multivariable regression analysis. ROC
curve determined ≥9.8 mm as predictor of reﬂux resolution (95% CI 0.825 to 0.998; p b 0.0001).
Conclusions: IO-US facilitates pediatric urologists to ﬁnd an optimal location, to reach a volcanomoundmorphol-
ogy and height, thus increasing intraoperative accuracy. IO-US also helps evaluating high-risk recurrence and
guiding prognostic counseling.
Type of study: Treatment study.
Level of evidence: II.
© 2017 Elsevier Inc. All rights reserved.Ultrasonography (US) represents one of themost time-efﬁcient, cost-
effective and noninvasive imaging modalities currently applied to Pedi-
atric Urology, being the prime choice in both diagnosis and follow-up
of many pathologies. Different subspecialties apply US to intraoperative
surgical planning, such as Urology [1], Gynecology [2], and Cardiac Sur-
gery [3]. Advantages in surgical and imaging technology permit the per-
formance of combined procedures in a safe and efﬁcient way.
Vesicoureteral Reﬂux (VUR) is a common urological disease, affecting
approximately 1% of pediatric population and eventually leading to renal
damage [4]. There are nowmanymanagement options available for pedi-
atric VUR, includingwatchfulwaiting,medical treatmentwith continuous
antibiotic prophylaxis and various surgical alternatives, headed by the
rapid growth in the use of endoscopic treatment within the last decades
[5]. Endoscopic treatment is effective and well tolerated in children and
long-term follow up indicates no deterioration in patients responding
positively to treatment [6]. However, owing to inadequate intraoperativeepartment of Mother and Child
0127 Palermo, Italy. Tel.: +39
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.org/10.1016/j.jpedsurg.2017.indicators andvariable success rate, International guidelines still prescribe
postoperative Voiding Cystourethrogram (VCUG) to assess reﬂux resolu-
tion [7]. Unfortunately, VCUG remains a distressing anduncomfortable in-
vestigation for children and their parents, graved by concern for radiation
exposure, particularly in children who should undergo long term follow-
upexaminations. Recently some authors identiﬁedultrasoundmound ap-
pearance as a potential predictor of success of the procedure [8–10].
Moreover many technical variables could play a role in determining suc-
cessful outcome, such as ureteral hydrodistention, bladder ﬁlling, and
height of the obtained mound.
In this paperwas analyzedwhether intraoperative USmoundvisual-
ization, localization and measurement could improve surgical accuracy
and perioperative counseling, thus potentially decreasing the need for
postoperative VCUG and personalizing follow-up.
1. Materials and methods
1.1. Indication and preoperative evaluation
Patients undergoing endoscopic subureteral injection of dextranomer/
hyaluronic acid copolymer (Dx/HA) for primary VUR were prospectivelysisted approach for endoscopic treatment of vesicoureteral reﬂux in
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nosed by VCUG and graded based on the International Reﬂux Study by an
expert radiologist. Patients with VUR less than 1 year of age were initially
managed with antibiotic prophylaxis and monthly urine analysis and
reevaluated at 1 year of age.
Preoperative evaluation included sex, age, VUR grade and laterality,
physical examination, renal and bladder ultrasound scan (RBUS) and es-
timation of theoretical bladder capacity for each children.
Indications for endoscopic treatment included repeated infections
on antibiotic prophylaxis, presence of scarring at renal scintigraphy
and/or moderate to high grade reﬂux. Patients with low grade (I–II
monolateral VUR), history of neurogenic bladder, overactive bladder,
genitourinary anomalies or other complex syndromes were excluded
from endoscopic procedure and assigned to other treatment options.
Parents gave written informed consent, after being informed about
the nature of the study, in accordance with the Helsinki declaration.
1.2. Technique
All procedures were performed under general anesthesia with the
patient in supine position, by a single experienced surgeon. Using a 9
Fr cystoscope, endoscopic injections were performed with either
STING or Double Hit technique as described by Puri and Kirsch [11,12]
according to surgeon's preference. Bladder was kept half full, avoiding
overdistention. At the same time, intraoperative ultrasound (IO-US)
was performed by an expert pediatric radiologist. The equipment used
included the CX50, Philips, US system with a high-resolution 8–5 MHz
curved-array transducer. Ultrasonographic intraoperative bladder ex-
amination was performed with sagittal scan in order to better visualize
ureteral course.
IO-US rating was based on combined variables: mound location and
height. Mound location depended on both anatomy and needle place-
ment. Needle placement at ureteral oriﬁcewas detected by sonographic
identiﬁcation of ureteral jet and hydrodistention during endoscopic
procedure, and thus localizationwas classiﬁed as poor, good or optimal.
Moreover, IO-US allowed mound measurement simultaneously with
surgical procedure; height wasmeasured as themaximal vertical diam-
eter of the hyperechogenic round shaped mass visualized at ureteral
oriﬁce. Mound height was as well classiﬁed as poor, good, optimalFig. 1.Main steps of surgical procedure compared to IO-US: on the left IO-US views and on th
ureteral catheter); (B) optimal ureteral placement and initial mound formation (arrow init
arrowhead needle); (D) ﬁnal mound appearance (arrow mound; white arrowhead ureteral jet
Please cite this article as: Zambaiti E, et al, Intraoperative ultrasound-as
children, J Pediatr Surg (2017), http://dx.doi.org/10.1016/j.jpedsurg.2017.according to reached height. Based on previous studies on mound
height [13] and reabsorption rate [14], an optimal Dx/HA volcanoheight
at US was considered for mounds higher than 11 mm, good from 11 to
9 mm, and poor less than 9 mm. Fig. 1 highlights main steps comparing
surgical and IO-US views. The bladder was ﬁnally emptied and the pro-
cedure terminated. At the end of the surgical procedure, the surgeon's
opinion regarding possible success was collected.
1.3. Postoperative protocol
An indwelling catheter was left into the bladder for 24 h after cysto-
scopic procedures in order to allow the stabilization of implants at the
lowest pressure; patients were discharged after catheter removal,
RBUS and spontaneous micturition. Postoperative follow-up protocol
planned at our Institution consisted of routine RBUS and VCUG accord-
ing to guidelines. Antibiotic prophylaxis was administrated until com-
plete VUR resolution was conﬁrmed by VCUG, performed 3 months
postoperatively. The same radiologist performedpreoperative andpost-
operative VCUG evaluation, blinded to IO-US. Postoperative US evalua-
tion aimed to conﬁrm presence and location of Dx/HA and was
performed by the same radiologist performing IO-US. US follow-up
lasted for all patients for at least 1 year following endoscopic injection.
Urine analysis was usually requested on demand, if febrile urinary
tract infection (UTI) was suspected.
1.4. Statistical analysis
Statistical analysis of quantitative and qualitative data, including de-
scriptive statistics, was performed for all items. Continuous data are
expressed as mean ± SD, unless otherwise speciﬁed. Baseline differ-
ences between groups were assessed by the chi-square test or Fisher
exact test, as needed for categorical variables, and by the univariate
analysis of variance (ANOVA) for parametric variables. Logistic regres-
sion analysis examined the correlation between patient characteristics
(independent variables), and success of the procedure (dependent var-
iable) in simple and multiple regression models. Multinomial logistic
regression analysis was used for nominal variables as VUR grade, local-
ization and mound height evaluation. To assess the predictive rate of
different cutoff values of postoperative mound height at US scan withe right endoscopic appearance. (A) Initial catheterization (arrow cystoscope; arrowheads
ial mound; arrowhead needle); (C) needle injecting Dx/HA positioned (arrow mound;
; black arrowheads ureteral course).
sisted approach for endoscopic treatment of vesicoureteral reﬂux in
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Fig. 2. ROC curve: mound height ≤ 9.8 mm is a predictor of reﬂux resolution (sensitivity
100%, speciﬁcity 74.2%, area under the curve 0.911, 95% CI 0.825 to 0.998; p b 0.0001).
3E. Zambaiti et al. / Journal of Pediatric Surgery xxx (2017) xxx–xxxregard to success rate, a receiver operating characteristic (ROC) curve
with calculations of area under the curve and 95% CI was constructed,
and sensitivity and speciﬁcity values were calculated. All predictability
analysis have been performed “per ureter”.
Data were analyzed by IBM SPSS Software 22 version (IBM Corp.,
Armonk, NY, USA). All p-values were two-sided and p ≤ 0.05 was con-
sidered statistically signiﬁcant.
2. Results
We analyzed a total of 26 consecutive patients, accounting for 41
ureters,whounderwentDx/HA injection for grade 2 to 5 VUR conﬁrmed
by preoperative VCUG. Of the 26 patients, 15 were females. VUR was
unilateral in 11 (42.3%) and bilateral in 15 (57.7%) children. Of the 41
ureters, 18 were right-sided and 23 left-sided. Preoperative VUR grade
was 2, 3, 4 and 5 in 14.6% (n = 6), 51.2% (n = 21), 24.4% (n = 10),
and 9.8% (n = 4) of the ureters respectively. 25 ureters were treated
with Double Hit technique (61%) and 16 with STING injection of Dx/
HA (39%). Average age at surgery was 44.5 (SD ± 32) months, ranging
from 12 months to 9 years.
Intraoperative mound reached an optimal height in 7 patients
(17.1%), good in 25 (61%) and poor in 9 (22%); while localization was
classiﬁed as optimal in 24 patients (58.5%), good in 13 (31.7%) and
poor in 4 (9.8%). The average volume of Dx/HA injected was 0.82
(SD ± 0.35) mL.
Overall cure rate, deﬁned as noVUR at VCUG,was 75.6% by ureter. Of
the 10 failures of the procedure, half showed a downgrading of the re-
ﬂux and were treated by a second injection, 3 patients (accounting for
5 ureters) were treated by open surgery. During US follow-up lasting
for at least 1 year, none of the patients evaluated as “cured” experienced
febrile UTI or other symptoms related to a possible recurrence, needing
a second VCUG.
A statistically signiﬁcant relationship was found between postoper-
ative VCUG and IO-US mound height (p = 0.003, Chi-Square Tests) or
localization (p b 0.0005, Chi-Square Tests). Moreover, success of endo-
scopic treatment group had a mean mound height of 10.62 ±
1.36 mm while persistence of reﬂux group had a mean mound height
of 8.39 ± 1.08 mm (p b 0.0005, ANOVA test). Technique was also dem-
onstrated to inﬂuence success of theprocedure (p=0.030, Pearson Chi-
Square).
Logistic regression analysis in the simple model conﬁrmed a rela-
tionship between both mound height evaluation and height expressed
in mm, and success of endoscopic treatment (OR = 0.85 CI 95%;
0.016–0.441; p = 0.003 and OR = 0.265 CI 95%; 0.114–0.613; p =
0.002 respectively). Multivariable regression model conducted by eval-
uation of all different variables, even not signiﬁcant,maintained a signif-
icant correlation between success of endoscopic treatment group with
mound height (OR =0.103; 0.013–0.802; p = 0.030).
The other analyzed factors do not correlate with success/failure of
the procedure: no differences were found according to sex (p =
0.270, Fisher exact test), VUR grade (p = 0.399, Pearson Chi-Square),
side of the VUR (p= 1.0, Fisher exact test) or volume of Dx/HA injected
(p = 0.182, ANOVA test). Surgeon's impression on procedure was also
demonstrated not to correlate with success (p = 0.082, Fisher's exact
test).
The ROC curve analysis (Fig. 2) showed that themound height value
≥9.8mm is a predictor of reﬂux resolutionwith a sensitivity of 100% and
a speciﬁcity of 74.2%, with an area under the ROC curve of 0.911 (95% CI
0.825 to 0.998; p b 0.0001).
3. Discussion
Treatment options for VUR in children are various, ranging from
watchful waiting through medical treatment and minimally invasive
endoscopic procedures to open surgical correction. Different procedures
have been described for surgical ureteral reimplantation, open orPlease cite this article as: Zambaiti E, et al, Intraoperative ultrasound-as
children, J Pediatr Surg (2017), http://dx.doi.org/10.1016/j.jpedsurg.2017.laparoscopic, all associated with a high success rate (up to 98–100%).
Accordingly, postoperative VCUG is nowadays considered unnecessary
after an uncomplicated open ureteral reimplantation [15]. Disadvan-
tages of open procedures are short-term morbidity, longer hospitaliza-
tion and high stress for both children and parents. Medical treatment
is a less invasive option but long-term use of antibiotics and renal scar
formation owing to high pressures are still matters of concern. The in-
troduction of endoscopic treatment has been welcomed as a minimally
invasive and safe treatment option by many pediatric urologists and
constitutes today a valid ﬁrst line treatment for VUR. Success rates re-
ported in literature range from 69 to 90% [16]. Despite this relatively
high success rate, clear factors predicting success of endoscopic injec-
tion of Dx/HA are still lacking. This is one of the reasons behind recent
guideline recommendation on the need for a postoperative VCUG to as-
sess VUR resolution. Moreover, it is well known and demonstrated that
success rate of resolution of reﬂux on VCUG is related to the timing of
the investigation [17] and some parents would probably choose a non-
invasive follow-up [18].
Multiple groups have suggested different prognostic factors that
could inﬂuence success of endoscopic procedure [19]. These commonly
include preoperative VUR grade [20], presence of complicating anatomy
[21,22], presence of voiding dysfunction [23], surgeon skill/experience
[24,25], injected volume and technique of injection [26], intraoperative
mound endoscopic appearance [27], and outcome deﬁnition [6,28].
The aim of endoscopic treatment is to create a submucosal mound
with coaptation of ureteral oriﬁce. This has historically meant to be
achievement of an endoscopic “volcano” appearance. However, recent-
ly, many authors tried to demonstrate US appearance of Dx/HA as a pos-
sible predictor, meaning the mound formation not only surgically, but
also sonographically demonstrable.
Park et al. [8] demonstrated a good correlation between postopera-
tive US 1 month after injection therapy and VCGU results. Implant vol-
umes were not precisely measured, but large retained implants were
associated with treatment success, while small or nonvisualized im-
plants were related to the persistent reﬂux. Kajbafzadeh et al. [29] re-
ported that reduction or absence of a mound on postoperative US is a
major predictor of treatment failure, whereas visualization of the
mound on postoperative US can predict VUR resolution. McMann et al.
[9] evaluated the correlation between volume retention of the implantsisted approach for endoscopic treatment of vesicoureteral reﬂux in
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Fig. 3. Flow chart for management of children with Vesicoureteral Reﬂux based on IO-US. VCUG: Voiding Cystourethrogram; Dx/HA: dextranomer/hyaluronic acid copolymer; IO-US:
Intraoperative ultrasound; UTI: urinary tract infections.
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retained implants compared to small retained (75%) or nonvisualized
implants (70%). The same authors also estimated a positive predictive
value (PPV) of 89% for the presence of mound on ultrasound imaging
and prediction of VUR resolution at VCUG. Similar resultswere obtained
byOzcan et al. [10]who suggested a PPV of 86.3% based on 19 of 22 ure-
ters with an identiﬁable mound that had no VUR on VCUG.
Conversely, some authors reported a poor correlation between
mound visualization and prediction of VUR resolution [30,31]. Notwith-
standing, limits of both these reports are the retrospective design of the
study, US performed by radiology staff, not speciﬁcally asked to identify
Dx/HA mounds, and only subsequently interpreted by the authors.
Dx/HA is a partially biodegradable substance; hydrolysis of the
dextranomer microspheres can cause a volume decrease following in-
jection. In fact, Stenberg et al. [14] experimentally demonstrated a 23%
of reduction of volume in subcutaneous implanted mounds after
1 year in rats. In 2003 Kirsch et al. ﬁrstly described in humans a 20% re-
duction using a volumetric analysis with sonography 3months after en-
doscopic injection [32] and further conﬁrmed in 2007 that an initial 25%
reduction at 2 weeks remained durable with insigniﬁcant volume re-
duction up to 36 months postoperatively [9].
Moreover, the possibility of migration of the implant could render
the implant ineffective, even though the surgeonmay obtain satisfacto-
ry endoscopic implant morphology. Park et al. stated that assessment of
the volume and location of the implant should be determined using
postoperative US because the intraoperative implant morphology may
change with time [8]. Ellsworth et al. [30] postulated the identiﬁcation
of ureteral jet in relation to themound for a proper location and they ad-
vocate the need for a real-time ultrasonography.
The present study underlines that IO-US could be an aid in both
mound height assessment and location. Mound measurement appears
to be a crucial aspect: it constitutes a feasible and reproductive measure
and could become a newpredictor of reﬂux resolution. The intraoperative
height constitutes a starting point to evaluate reabsorption rate and it al-
lows to hypothesize long termUS follow-up as adequate and safe, proba-
bly outmatching the need of postoperative VCUG in selected cases. IO-US
also enables an optimal location: cystoscopic hydrodistention and identi-
ﬁcation of ureteral jet during sonographic evaluation are importantPlease cite this article as: Zambaiti E, et al, Intraoperative ultrasound-as
children, J Pediatr Surg (2017), http://dx.doi.org/10.1016/j.jpedsurg.2017.milestones for localization of ureteral oriﬁce and thus mound forma-
tion. In our experience, sagittal bladder scan allows a better visualiza-
tion of ureteral course and combined with endoscopic view offers a
high accuracy and precise initial placement when creating the mound.
Moreover, it gives important landmarks useful for US follow-up,
especially to determine whether postoperative dislocation could even-
tually occur.
The present study has some criticism. The main limitation is the re-
duced number of patients involved. For this reason, results presented in
the present paper cannot be considered conclusive but indicative of pre-
liminary observations needing further conﬁrmation. Second, Dx/HA re-
absorption rate sonographically measured is unknown. Third, a single
radiologist, blinded to VCUG results, took all US measurements. Al-
though this approach reduces measurement bias, the procedure be-
come operator-dependent. Fourth, mound localization could vary
depending not only on needle positioning but also on anatomy of the
ureterovesical junction. The analysis of a broader group of patients, in-
cluding even the functional and anatomical characteristics of every pa-
tient related to the outcome may help to better understand mound
formation and even failures. In order to overcome other raised criticisms
a large series with US evaluation of mound height for a strict and
prolonged follow-up is needed to further conﬁrm present ﬁndings, to
determine which IO-US mound height is the better cutoff value for
VUR resolution and eventually reduce the need for VCUG in a selected
group of patients.
Optimal localization and mound height during IO-US could modify
current postoperative management in children undergoing endoscopic
procedure for VUR; US analysis of mounds cannot replace VCUG for sci-
entiﬁc demonstration of reﬂux resolution after injection therapy, but it
may have a place in daily clinical work. Fig. 3 summarizes a proposed al-
gorithm for management of children with VUR based on IO-US. IO-US
has been shown to be an important prognostic tool, useful for both peri-
operative counseling and personalized postoperative follow-up.
4. Conclusion
IO-US is a feasible and repeatable aid during endoscopic procedures
for VUR treatment in children.sisted approach for endoscopic treatment of vesicoureteral reﬂux in
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5E. Zambaiti et al. / Journal of Pediatric Surgery xxx (2017) xxx–xxxIntraoperative mound measurement is a helpful tool for both endo-
scopic procedure and prognostic evaluation. Intraoperative monitoring
could guide surgeons to identify precise injection site and reach an ad-
equate mound thus increasing prognostic accuracy. Postoperative
follow-up allows to evaluate reabsorption rate and to assess implants
location. Precise knowledge of US measured reabsorption rate together
with intraoperative monitoring, mound evaluation and location could
ﬁnally decrease the need for postoperative VCUG.
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